Return to code system index

substanceAdminSubstitution      [2.16.840.1.113883.5.1070]

Description:

Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

Lvl- Typ Concept Code
  Head Code-defined Value Set
Print Name Definition, Properties, Relationships
0-A _ActSubstanceAdminSubstitutionCode
 v:ActSubstanceAdminSubstitutionCode
ActSubstanceAdminSubstitutionCode

Definition:

Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

Concept Relationships:
  Generalizes (derived): E F N

1-S E equivalent

Definition:

Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

Concept Relationships:
  Specializes: _ActSubstanceAdminSubstitutionCode
  Generalizes (derived): EC TE

2-S . . EC equivalent composition

Definition:

Description:

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril

Concept Relationships:
  Specializes: E
  Generalizes (derived): BC G

3-L . . . BC brand composition

Definition:

Description:

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven

Concept Relationships:
  Specializes: EC

3-L . . . G
. . .   v:SubstanceAdminGenericSubstitution
generic composition

Definition:

Description: Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)

Concept Relationships:
  Specializes: EC

2-S . . TE therapeutic alternative

Definition:

Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet

Concept Relationships:
  Specializes: E
  Generalizes (derived): TB TG

3-L . . . TB therapeutic brand

Definition:

Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet

Concept Relationships:
  Specializes: TE

3-L . . . TG therapeutic generic

Definition:

Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine

Concept Relationships:
  Specializes: TE

1-L F formulary

Definition:

Description: This substitution was performed or is permitted based on formulary guidelines.

Concept Relationships:
  Specializes: _ActSubstanceAdminSubstitutionCode

1-L N none

Definition:

No substitution occurred or is permitted.

Concept Relationships:
  Specializes: _ActSubstanceAdminSubstitutionCode


Return to code system index